搜索





搜索





市场行情
/
股票
/
crsp
/

CRISPR Therapeutics AG

CRSP

添加自选

47.640USD

+0.090+0.19%

收盘 07-29 16:00（美东）报价延迟15分钟

4.59B总市值

亏损市盈率 TTM

CRISPR Therapeutics AG

47.640

+0.090+0.19%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

CRSP 利润表

您可以在这里找到CRISPR Therapeutics AG的年度或季度收入报告，以深入了解CRISPR Therapeutics AG的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

FY2016Q4

FY2016Q3

FY2016Q2

FY2016Q1

FY2015Q4

FY2015Q3

FY2015Q2

FY2015Q1

营业总收入

68.55%1.46M

-97.58%864.00K

47.67%889.00K

72.53%892.00K

71.63%865.00K

-82.26%35.69M

--602.00K

-99.26%517.00K

-99.50%504.00K

3353333.33%201.21M

-100.00%0.00

44203.80%70.00M

10538.30%100.00M

-99.95%6.00K

-88.59%94.00K

-99.98%158.00K

74.40%940.00K

3386.22%12.90M

456.76%824.00K

2046947.73%900.70M

243.31%539.00K

-99.52%370.00K

-99.93%148.00K

-86.16%44.00K

-52.13%157.00K

66870.43%77.02M

37542.63%211.93M

-70.77%318.00K

-75.85%328.00K

-99.64%115.00K

-76.41%563.00K

-69.63%1.09M

-49.76%1.36M

1279.05%32.33M

54.10%2.39M

350.57%3.58M

467.86%2.70M

848.99%2.34M

--1.55M

--795.00K

--476.00K

--247.00K

--0.00

营业收入

68.55%1.46M

-97.58%864.00K

47.67%889.00K

72.53%892.00K

71.63%865.00K

-82.26%35.69M

--602.00K

-99.26%517.00K

-99.50%504.00K

3353333.33%201.21M

-100.00%0.00

44203.80%70.00M

10538.30%100.00M

-99.95%6.00K

-88.59%94.00K

-99.98%158.00K

74.40%940.00K

3386.22%12.90M

456.76%824.00K

2046947.73%900.70M

243.31%539.00K

-99.52%370.00K

-99.93%148.00K

-86.16%44.00K

-52.13%157.00K

66870.43%77.02M

37542.63%211.93M

-70.77%318.00K

-75.85%328.00K

-99.64%115.00K

-76.41%563.00K

-69.63%1.09M

-49.76%1.36M

1279.05%32.33M

54.10%2.39M

350.57%3.58M

467.86%2.70M

848.99%2.34M

--1.55M

--795.00K

--476.00K

--247.00K

--0.00

营业费用

-11.78%131.71M

55.20%155.63M

20.06%132.95M

-11.74%133.96M

5.81%149.29M

-23.81%100.28M

-16.37%110.73M

-8.14%151.78M

-14.22%141.09M

0.06%131.62M

-27.44%132.41M

-9.92%165.22M

-7.02%164.49M

-17.06%131.55M

40.72%182.48M

32.83%183.42M

53.73%176.91M

46.67%158.60M

40.12%129.67M

71.04%138.08M

56.06%115.08M

63.75%108.13M

27.19%92.55M

45.99%80.73M

51.26%73.74M

45.63%66.03M

45.54%72.77M

44.11%55.30M

71.93%48.75M

44.62%45.34M

92.61%49.99M

54.19%38.37M

20.93%28.36M

13.38%31.35M

60.63%25.96M

43.42%24.89M

93.33%23.45M

122.78%27.65M

160.54%16.16M

378.70%17.35M

224.63%12.13M

--12.41M

--6.20M

--3.63M

--3.74M

研发费用

-5.39%68.57M

1.67%83.53M

-28.31%58.90M

-12.81%69.89M

-4.84%72.48M

-13.65%82.16M

-9.41%82.16M

-21.06%80.17M

-23.78%76.17M

-8.12%95.14M

-22.23%90.70M

-17.58%101.56M

-15.48%99.94M

-22.99%103.56M

10.73%116.62M

13.80%123.22M

30.56%118.25M

63.26%134.47M

48.32%105.32M

82.35%108.28M

67.12%90.56M

68.92%82.36M

24.04%71.01M

50.20%59.38M

60.23%54.19M

69.30%48.76M

43.76%57.25M

54.23%39.53M

73.28%33.82M

43.79%28.80M

123.14%39.82M

49.73%25.63M

31.84%19.52M

28.63%20.03M

48.07%17.84M

99.02%17.12M

146.26%14.80M

152.22%15.57M

221.47%12.05M

478.87%8.60M

416.49%6.01M

--6.17M

--3.75M

--1.49M

--1.16M

折旧摊销及损耗

-8.80%4.32M

16.91%5.66M

-7.65%4.43M

-4.05%4.65M

-2.01%4.74M

-1.18%4.84M

-2.54%4.80M

-3.10%4.84M

-4.32%4.83M

-16.18%4.90M

-1.85%4.92M

-31.21%5.00M

-16.36%5.05M

-6.63%5.85M

-5.75%5.02M

98.99%7.27M

122.43%6.04M

144.00%6.26M

128.01%5.32M

66.05%3.65M

29.29%2.71M

79.19%2.57M

79.62%2.33M

83.64%2.20M

110.00%2.10M

39.57%1.43M

47.23%1.30M

33.11%1.20M

21.07%1.00M

4.48%1.03M

10.38%883.00K

27.48%900.00K

14.72%826.00K

101.64%982.00K

238.98%800.00K

312.87%706.00K

526.09%720.00K

725.42%487.00K

490.00%236.00K

1121.43%171.00K

721.43%115.00K

--59.00K

--40.00K

--14.00K

营业利润

12.25%-130.25M

-139.62%-154.76M

-19.91%-132.06M

12.02%-133.07M

-5.57%-148.42M

-192.82%-64.59M

16.83%-110.13M

-58.85%-151.26M

-118.01%-140.59M

152.90%69.58M

27.40%-132.41M

48.04%-95.22M

63.35%-64.49M

9.72%-131.54M

-41.55%-182.39M

-124.03%-183.26M

-53.63%-175.97M

-35.20%-145.70M

-39.45%-128.85M

1045.13%762.62M

-55.66%-114.54M

-1081.16%-107.76M

-166.40%-92.40M

-46.75%-80.69M

-51.96%-73.59M

124.28%10.98M

381.52%139.16M

-47.46%-54.98M

-79.36%-48.42M

-4753.09%-45.23M

-109.72%-49.43M

-75.00%-37.29M

-30.14%-27.00M

103.84%972.00K

-61.33%-23.57M

-28.67%-21.31M

-78.03%-20.74M

-108.04%-25.31M

-135.57%-14.61M

-356.77%-16.56M

-211.88%-11.65M

---12.17M

---6.20M

---3.63M

---3.74M

净非营业利息收入（费用）

利息费用

----

--0.00

----

--0.00

-100.00%0.00

--0.00

-100.00%0.00

----

-87.50%1.00K

-100.00%0.00

--8.05M

--99.00K

--8.00K

--1.00K

--0.00

股权收益

----

--0.00

100.00%0.00

-238.93%-3.43M

12.23%-1.01M

6.05%-1.02M

-124.94%-1.02M

-181.89%-1.01M

-128.32%-1.15M

-144.62%-1.09M

98.74%-453.00K

---359.00K

26.38%-505.00K

---446.00K

---35.85M

--0.00

---686.00K

----

--0.00

----

特殊收入（费用）

----

--0.00

---96.25M

----

--0.00

----

--0.00

-100.00%0.00

--0.00

--11.48M

--0.00

其他非经营性收入（费用）

-39.75%8.16M

-11.48%24.77M

4.68%26.24M

-15.58%22.07M

-45.24%13.54M

39.91%27.98M

21.25%25.06M

42.01%26.14M

94.00%24.72M

74.04%20.00M

184.57%20.67M

419.36%18.41M

3410.19%12.74M

422.99%11.49M

559.76%7.26M

372.53%3.54M

-81.43%363.00K

282.09%2.20M

588.13%1.10M

-46.88%750.00K

-53.80%1.96M

-97.06%575.00K

-94.60%160.00K

-40.70%1.41M

276.18%4.23M

1864.02%19.56M

2380.00%2.96M

1436.13%2.38M

992.86%1.13M

-2804.88%-1.11M

-83.10%-130.00K

196.27%155.00K

-2000.00%-126.00K

-99.95%41.00K

5.33%-71.00K

-301.25%-161.00K

95.89%-6.00K

160416.33%78.65M

-933.33%-75.00K

175.86%80.00K

-105.63%-146.00K

--49.00K

--9.00K

--29.00K

---71.00K

税前利润

9.49%-122.09M

-255.08%-130.00M

-24.40%-105.82M

-65.65%-207.26M

-16.42%-134.89M

-140.87%-36.61M

23.87%-85.07M

-62.88%-125.12M

-123.92%-115.87M

174.62%89.58M

36.19%-111.74M

57.26%-76.82M

70.53%-51.74M

16.34%-120.05M

-37.09%-175.12M

-123.54%-179.72M

-55.97%-175.61M

-33.88%-143.50M

-38.50%-127.75M

1062.91%763.37M

-62.34%-112.59M

-450.90%-107.19M

-166.50%-92.24M

-47.87%-79.28M

-43.52%-69.35M

164.50%30.55M

374.25%138.70M

-40.04%-53.61M

-71.27%-48.32M

-8556.43%-47.36M

-110.73%-50.57M

-74.24%-38.28M

-33.11%-28.21M

-96.80%560.00K

-63.42%-24.00M

-28.01%-21.97M

-153.36%-21.20M

243.24%17.50M

-136.83%-14.69M

-377.18%-17.16M

-119.75%-8.37M

---12.22M

---6.20M

---3.60M

---3.81M

所得税

-24.35%839.00K

-12.29%614.00K

-29.34%619.00K

0.39%1.29M

53.18%1.11M

200.43%700.00K

112.62%876.00K

39.44%1.29M

-45.15%724.00K

102.46%233.00K

171.65%412.00K

-84.91%923.00K

-63.41%1.32M

-320.59%-9.48M

3.36%-575.00K

47.67%6.12M

527.48%3.61M

-1432.65%-2.25M

-397.50%-595.00K

993.14%4.14M

52.52%575.00K

-3775.00%-147.00K

-27.01%200.00K

345.88%379.00K

343.53%377.00K

-98.29%4.00K

100.00%274.00K

-11.46%85.00K

-1.16%85.00K

-44.15%234.00K

-80.62%137.00K

-72.01%96.00K

-69.18%86.00K

4.75%419.00K

8737.50%707.00K

--343.00K

267.11%279.00K

471.43%400.00K

-94.77%8.00K

-100.00%0.00

126.67%76.00K

--70.00K

--153.00K

--69.00K

---285.00K

除税后利润

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

1053.13%759.23M

-62.29%-113.16M

-450.46%-107.04M

-166.78%-92.44M

-48.34%-79.66M

-44.05%-69.73M

164.18%30.54M

372.96%138.42M

-39.91%-53.70M

-71.05%-48.41M

-33851.77%-47.59M

-105.25%-50.71M

-71.99%-38.38M

-31.78%-28.30M

-99.18%141.00K

-68.14%-24.71M

-30.01%-22.32M

-154.38%-21.48M

239.17%17.10M

-131.26%-14.69M

-368.19%-17.16M

-139.69%-8.44M

---12.29M

---6.35M

---3.67M

---3.52M

持续经营利润

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

1053.13%759.23M

-62.29%-113.16M

-450.46%-107.04M

-166.78%-92.44M

-48.34%-79.66M

-44.05%-69.73M

164.18%30.54M

372.96%138.42M

-39.91%-53.70M

-71.05%-48.41M

-33851.77%-47.59M

-105.25%-50.71M

-71.99%-38.38M

-31.78%-28.30M

-99.18%141.00K

-68.14%-24.71M

-30.01%-22.32M

-154.38%-21.48M

239.17%17.10M

-131.26%-14.69M

-368.19%-17.16M

-139.69%-8.44M

---12.29M

---6.35M

---3.67M

---3.52M

归属少数股东的净利润

----

--0.00

----

100.00%0.00

----

100.00%0.00

93.75%-1.00K

-1300.00%-14.00K

69.57%-7.00K

98.95%-3.00K

---16.00K

---1.00K

---23.00K

---285.00K

归属于母公司的净利润

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

1053.13%759.23M

-62.29%-113.16M

-450.46%-107.04M

-166.78%-92.44M

-48.34%-79.66M

-44.05%-69.73M

164.18%30.54M

372.96%138.42M

-39.91%-53.70M

-71.05%-48.41M

-33851.77%-47.59M

-105.25%-50.71M

-71.99%-38.38M

-31.78%-28.30M

-99.18%141.00K

-68.30%-24.71M

-30.06%-22.32M

-154.47%-21.48M

239.36%17.10M

-131.07%-14.68M

-370.96%-17.16M

-160.70%-8.44M

---12.27M

---6.35M

---3.64M

---3.24M

归属于普通股东的净利润

9.61%-122.93M

-250.07%-130.61M

-23.85%-106.44M

-64.98%-208.55M

-16.64%-136.00M

-141.76%-37.31M

23.37%-85.94M

-62.60%-126.41M

-119.71%-116.59M

180.80%89.35M

35.75%-112.15M

58.17%-77.74M

70.39%-53.06M

21.72%-110.58M

-37.27%-174.55M

-124.48%-185.83M

-58.37%-179.22M

-31.96%-141.25M

-37.55%-127.15M

1053.13%759.23M

-62.29%-113.16M

-450.46%-107.04M

-166.78%-92.44M

-48.34%-79.66M

-44.05%-69.73M

164.18%30.54M

372.96%138.42M

-39.91%-53.70M

-71.05%-48.41M

-33851.77%-47.59M

-105.25%-50.71M

-71.99%-38.38M

-31.78%-28.30M

-99.18%141.00K

-68.30%-24.71M

-30.06%-22.32M

-154.47%-21.48M

239.36%17.10M

-131.07%-14.68M

-370.96%-17.16M

-160.70%-8.44M

---12.27M

---6.35M

---3.64M

---3.24M

基本每股收益

19.12%-1.28

-213.87%-1.37

-15.62%-1.17

-60.91%-2.40

-11.02%-1.58

-138.94%-0.44

28.60%-1.01

-51.44%-1.49

-111.34%-1.43

179.51%1.12

36.87%-1.41

59.00%-0.98

70.98%-0.67

23.48%-1.41

-34.23%-2.24

-123.94%-2.40

-54.07%-2.32

-22.77%-1.84

-26.47%-1.67

872.05%10.01

-31.65%-1.51

-382.20%-1.50

-152.20%-1.32

-28.45%-1.30

-23.32%-1.15

157.81%0.53

335.94%2.52

-23.22%-1.01

-50.64%-0.93

-26536.21%-0.92

-73.62%-1.07

-46.49%-0.82

-14.11%-0.62

-99.75%0.00

-66.87%-0.62

-29.58%-0.56

-154.62%-0.54

551.90%1.39

-131.08%-0.37

-370.97%-0.43

-160.69%-0.21

---0.31

---0.16

---0.09

---0.08

稀释每股收益

19.12%-1.28

-213.87%-1.37

-15.62%-1.17

-60.91%-2.40

-11.02%-1.58

-138.94%-0.44

28.60%-1.01

-51.44%-1.49

-111.34%-1.43

179.51%1.12

36.87%-1.41

59.00%-0.98

70.98%-0.67

23.48%-1.41

-34.23%-2.24

-125.40%-2.40

-54.07%-2.32

-22.77%-1.84

-26.47%-1.67

827.68%9.44

-31.65%-1.51

-396.15%-1.50

-154.84%-1.32

-28.45%-1.30

-23.32%-1.15

155.09%0.51

324.59%2.40

-23.22%-1.01

-50.64%-0.93

-26536.21%-0.92

-73.62%-1.07

-46.49%-0.82

-14.11%-0.62

-99.75%0.00

-66.87%-0.62

-29.58%-0.56

-154.62%-0.54

551.90%1.39

-131.08%-0.37

-370.97%-0.43

-160.69%-0.21

---0.31

---0.16

---0.09

---0.08

每股派息

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 CRISPR Therapeutics AG 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 CRSP 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

CRISPR Therapeutics AG 财年末的营收是多少？



CRISPR Therapeutics AG 2025 财年营收为 3.51M，高于上一财年的37.31M。

CRISPR Therapeutics AG 最近一个季度的营收是多少？



CRISPR Therapeutics AG 最近一个季度的营收为 1.46M，同比增长 68.55%。

CRISPR Therapeutics AG 全年的净利润是多少？



CRISPR Therapeutics AG 2025 财年净利润为 -581.60M。

CRISPR Therapeutics AG 上一季度的净利润是多少？



CRISPR Therapeutics AG 最近一个季度的净利润为 -122.93M。

CRISPR Therapeutics AG 年度营业利润是多少？



CRISPR Therapeutics AG 2025 财年的营业利润为 -568.32M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。